Neurology Minute podkast

The Amyloid Hypothesis for Alzheimer's disease and Aducanumab

0:00
1:57
Do tyłu o 15 sekund
Do przodu o 15 sekund

Dr. Erik Musiek discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer's disease.

Więcej odcinków z kanału "Neurology Minute"